The development of the nanoparticles combined with growth factors as the delivery system
-
1
West China Hospital of Stomatology, Sichuan University, State Key Laboratory of Oral Diseases, China
More and more attention focuses on the application of nanoparticles combined with growth factors (NPs/GFs), due to their substantial functions of GFs in regenerative medicine and disease treatments. In recent years, researchers redesign the materials and structures in the advanced modification of NPs/GFs, which can provide better effects than original models. On the basis of that, NPs/GFs are characterized by its specificity and diversity in functions, which are manifested in its wide range of application and bright perspectives. However, it is inevitable for NPs/GFs to overcome numerous obstacles before coming into force in vivo, particularly in its oral administration. The aim of study was to review recent original studies about NPs/GFs, involving the components and fabrication, focusing on materials, structures, functions and obstacles, and thus highlights the existing problems and figures out the future perspectives.
Sichuan university innovation foundation (201510610628; 201510611940; 201510610118; 201510610119)
Keywords:
cytokine,
nanoparticle,
delivery,
vehicle
Conference:
10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.
Presentation Type:
Poster
Topic:
Nano-structured materials for unique functions
Citation:
Chu
C,
Cao
Y,
Yin
Y,
Deng
J,
Qi
W and
Huang
H
(2016). The development of the nanoparticles combined with growth factors as the delivery system.
Front. Bioeng. Biotechnol.
Conference Abstract:
10th World Biomaterials Congress.
doi: 10.3389/conf.FBIOE.2016.01.02043
Copyright:
The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers.
They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.
The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.
Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.
For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.
Received:
27 Mar 2016;
Published Online:
30 Mar 2016.